BioCryst (BCRX): Operatsion marja

BioCryst (BCRX) kompaniyasining korporativ logotipi

BioCryst innovatsion komplement inhibitorlariga investitsiya kiritish orqali kamyob kasalliklar segmentida yetakchiligini saqlab qolmoqda. Kompaniya hozirda operatsion zararsizlikka erishish uchun Orladeyo ning global ta'minotini kengaytirmoqda. Operatsion marja farqi daromadlilikning ushbu tiklanishini ko'rsatadi, bunda 42.50 ushbu metrikaning joriy darajasini ifodalaydi. Irsiy angioedemaga chalingan bemorlar orasida brendning eng yuqori obro'si uning terapiya sohasidagi ishonchli kashfiyotchi sifatidagi maqomini mustahkamlaydi.

BioCryst Pharmaceuticals, Inc. (BCRX): Operatsion foyda normasi 04.07.2022dan 19.11.2026gacha

BCRX (BioCryst Pharmaceuticals): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
biocryst.com asosiy tovari

Institutsional kapital BioCryst (BCRX) kompaniyasini uning biznes modelining barqarorligi nuqtai nazaridan baholaydi. Operatsion foyda marjasi soliqlar va foiz to'lovlarigacha bo'lgan tushumlar orasida asosiy faoliyatdan olingan foyda ulushini aks ettiradi. Ushbu ko'rsatkich buxgalteriya tuzatishlarini hisobga olmagan holda, real ishlab chiqarish samaradorligini o'lchaydi. BioCryst uchun yuqori marjalar inyeksiyalarni siqib chiqarayotgan oral preparatlarning tijorat muvaffaqiyatini tasdiqlaydi. Grafikdagi barqaror tendentsiya aktivning fundamental ishonchliligini kafolatlaydi.

Muhim raqobatchilar

ARGX (argenx N.V.) - Operatsion marja|Sotuvning operatsion rentabelligi BioNTech Pharma BNTX|Sotuvning operatsion marjasi ABVX (ABIVAX)|Operatsion marja ADMA Biologics, Inc. (ADMA)|Operatsion marja PTGX (protagonist-inc.com)|IMVT: Operatsion foyda bo'yicha sotuv rentabelligi|KNSA - Operatsion rentabellik|GRFS: Operatsion rentabellik|ADPT (Adaptive Biotechnologies) - Sotuvning operatsion marjasi|Operatsion foyda bo'yicha sotuv rentabelligi CLDX|Sotuvning operatsion marjasi AUPH|Sotuvning operatsion rentabelligi Vera Therapeutics Inc VERA|Sotuvning operatsion marjasi DNTH (Dianthus Pharma)|Operatsion faoliyat rentabelligi Pharvaris N.V.|AbCellera Biologics Inc - Sotuvning operatsion marjasi|Tourmaline Bio (TRML) - Sotuvning operatsion rentabelligi|PGEN - Operatsion rentabellik|Operatsion foyda normasi PHAR (Pharming Group NV)|NKTR: Operatsion marja|Upstream Bio Corp - Operatsion foyda normasi|Operatsion rentabellik Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Operatsion faoliyat rentabelligi|Operatsion marja GOSS|Sotuvning operatsion marjasi KalVista Pharmaceuticals, Inc. KALV|Operatsion rentabellik Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Sotuvning operatsion rentabelligi|SVRA - Operatsion rentabellik|Rigel Pharmaceuticals - Operatsion foyda koeffitsiyenti|AnaptysBio Corp (ANAB) - Operatsion rentabellik|ATXS - Operatsion faoliyat rentabelligi|Operatsion rentabellik enGene Holdings Inc.|RAPT: Operatsion foyda normasi|Operatsion marja JBIO|Sotuvning operatsion marjasi aclaristx.com ACRS|Operatsion rentabellik Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Sotuvning operatsion rentabelligi|Cabaletta Bio, Inc - Operatsion marja|Sotuvning operatsion rentabelligi Ventyx Biosciences|THTX (theratech.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Operatsion marja|Sotuvning operatsion rentabelligi Agenus Inc. AGEN|Sotuvning operatsion marjasi CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Operatsion foyda normasi|Operatsion rentabellik atyrpharma.com ATYR|Operatsion marja Adagene Corp ADAG|IMA - Operatsion rentabellik|Operatsion foyda normasi STTK (Shattuck Labs)|EQ: Operatsion marja|Connect Biopharma (CNTB) - Operatsion marja|Operatsion rentabellik Immunic|Operatsion marja atarabio.com|Operatsion marja IFRX|Operatsion marja X4 Pharma (XFOR)|Operatsion marja ACET (adicetbio.com)|Operatsion marja Celularity Inc. CELU|INMB - Operatsion rentabellik|Operatsion foyda normasi BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi SAB Biotherapeutics Inc.|Sotuvning operatsion marjasi AKTX|Sotuvning operatsion marjasi enlivex.com (ENLV)|Operatsion rentabellik Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Operatsion foyda bo'yicha marjinallik|Operatsion marja EDSA (Edesa Biotech Corp)|Operatsion faoliyat rentabelligi iBio (IBIO)|CARM - Operatsion rentabellik|XTL Biopharmaceuticals (XTLB) - Sotuvning operatsion marjasi|BOLT: Operatsion marja|Sotuvning operatsion marjasi HCW Biologics Inc.|Operatsion rentabellik Aptevo|Operatsion foyda bo'yicha sotuv rentabelligi AIM (AIM ImmunoTech, Inc.)|Operatsion marja ADTX|Operatsion faoliyat rentabelligi GRI Bio Corp|Operatsion marja XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Sotuvning operatsion rentabelligi|Revelation Biosciences Corp - Operatsion marja|INDP (Indaptus Therapeutics, Inc.) - Operatsion foyda bo'yicha sotuv rentabelligi|SCNI: Operatsion marja|CALI - Operatsion faoliyat rentabelligi|AFMD (Affimed N.V.) - Operatsion marja|Operatsion rentabellik ALLK|Sotuvning operatsion marjasi HOOK (HOOKIPA Pharma, Inc.)|IGMS - Sotuvning operatsion rentabelligi|Operatsion rentabellik iTeos ITOS|Ocean Bio - Operatsion rentabellik|TC BioPharm Ltd - Operatsion marja|Sotuvning operatsion rentabelligi thirdharmonicbio.com